Skip to content

Q2 FY24 Earnings Results

Q2 FY24 earnings, Jul–Sep 2023: 5,345 Indian listed companies have reported; median profit growth is 0.0% on last year. Quarter ended 30 Sep 2023.

Clear filters 1–100 of 232
CompanyRevenue (₹ Cr)Profit (₹ Cr)Per share8Q profit
Symbol Sector Reported YoY QoQ Reported YoY EPS vs consensus Trend
SUNPHARMA Sun Pharmaceutical Industries LtdHealthcare12,192n/aup+2.1%2,385n/a9.90No estimate
AUROPHARMA Aurobindo Pharma LtdHealthcare7,219n/aup+5.4%752n/a12.92No estimate
DRREDDY Dr Reddys Laboratories LtdHealthcare6,903n/aup+2.1%1,482n/a17.77No estimate
CIPLA Cipla LtdHealthcare6,678n/aup+5.5%1,155n/a14.01No estimate
LUPIN Lupin LtdHealthcare5,039n/aup+4.7%495n/a10.76No estimate
ZYDUSLIFE Zydus Lifesciences LtdHealthcare4,369n/adown−15.0%803n/a7.91No estimate
BIOCON Biocon LtdHealthcare3,462n/aup+1.1%173n/a1.05No estimate
ALKEM Alkem Laboratories LtdHealthcare3,440n/aup+15.9%615n/a51.90No estimate
GLENMARK Glenmark Pharmaceuticals LtdHealthcare3,207n/aup+5.6%−62n/a−2.90No estimate
MANKIND Mankind Pharma LtdHealthcare2,708n/aup+5.0%511n/a12.51No estimate
TORNTPHARM Torrent Pharmaceuticals LtdHealthcare2,660n/aup+2.7%386n/a11.41No estimate
IPCALAB Ipca Laboratories LtdHealthcare2,034n/aup+28.3%136n/a5.72No estimate
PPLPHARMA Piramal Pharma LtdHealthcare1,911n/aup+9.3%5n/a0.04No estimate
DIVISLAB Divis Laboratories LtdHealthcare1,909n/aup+7.4%348n/a13.11No estimate
JUBLPHARMA Jubilant Pharmova LtdHealthcare1,680n/aup+5.9%62n/a3.92No estimate
EMCURE Emcure Pharmaceuticals LtdHealthcare1,663n/aup+6.9%146n/a7.69No estimate
APLLTD Alembic Pharmaceuticals LtdHealthcare1,595n/aup+7.3%137n/a6.95No estimate
ABBOTINDIA Abbott India LtdHealthcare1,494n/aup+1.0%313n/a147.27No estimate
GLAND Gland Pharma LtdHealthcare1,373n/aup+13.6%194n/a11.78No estimate
LAURUSLABS Laurus Labs LtdHealthcare1,224n/aup+3.6%37n/a0.69No estimate
GRANULES Granules India LtdHealthcare1,189n/aup+20.6%102n/a4.21No estimate
AKUMS Akums Drugs & Pharmaceuticals LtdHealthcare1,181n/aup+21.8%33n/a2.22No estimate
NATCOPHARM Natco Pharma LtdHealthcare1,031n/adown−9.6%369n/a18.81No estimate
AJANTPHARM Ajanta Pharma LtdHealthcare1,028n/aup+0.7%195n/a15.24No estimate
STAR Strides Pharma Science LtdHealthcare999n/aup+7.4%−149n/a−14.54No estimate
GLAXO Glaxosmithkline Pharmaceuticals LtdHealthcare957n/aup+25.6%218n/a12.84No estimate
SYNGENE Syngene International LtdHealthcare910n/aup+12.6%117n/a2.90No estimate
JBCHEPHARM J B Chemicals & Pharmaceuticals LtdHealthcare882n/adown−1.6%151n/a9.72No estimate
WOCKPHARMA Wockhardt LtdHealthcare753n/aup+16.9%−73n/a−5.34No estimate
AARTIDRUGS Aarti Drugs LtdHealthcare642n/adown−2.9%40n/a4.31No estimate
INDGN Indegene LtdHealthcare636n/aup+4.6%75n/a3.38No estimate
ALIVUS Alivus Life Sciences LtdHealthcare595n/aup+2.9%119n/a9.69No estimate
DCAL Dishman Carbogen Amcis LtdHealthcare587n/adown−18.8%−41n/a−2.61No estimate
PFIZER Pfizer LtdHealthcare575n/aup+8.3%149n/a32.56No estimate
IOLCP IOL Chemicals & Pharmaceuticals LtdHealthcare545n/adown−3.2%38n/a1.29No estimate
MARKSANS Marksans Pharma LtdHealthcare531n/aup+6.2%84n/a1.84No estimate
ERIS ERIS Lifesciences LtdHealthcare505n/aup+8.1%122n/a9.07No estimate
SANOFI Sanofi India LtdHealthcare491n/adown−4.7%152n/a66.17No estimate
FDC FDC LtdHealthcare486n/adown−9.3%70n/a4.29No estimate
INDOCO Indoco Remedies LtdHealthcare482n/aup+13.1%35n/a3.81No estimate
AARTIPHARM Aarti Pharmalabs LtdHealthcare440n/adown−3.9%52n/a5.72No estimate
HIKAL Hikal LtdHealthcare435n/aup+12.1%13n/a1.02No estimate
SOLARA Solara Active Pharma Sciences LtdHealthcare425n/an/a−17n/a−3.58No estimate
MOREPENLAB Morepen Laboratories LtdHealthcare422n/aup+5.2%21n/a0.42No estimate
NEULANDLAB Neuland Laboratories LtdHealthcare418n/aup+15.2%89n/a69.56No estimate
UNICHEMLAB Unichem Laboratories LtdHealthcare416n/adown−1.7%−24n/a−3.48No estimate
CAPLIPOINT Caplin Point Laboratories LtdHealthcare410n/aup+3.8%116n/a15.13No estimate
NECLIFE Nectar Lifescience LtdHealthcare398n/aup+1.0%1n/a0.05No estimate
VIYASH Viyash Scientific LtdHealthcare346n/aup+3.9%−7n/a−0.34No estimate
POLYMED Poly Medicure LtdHealthcare337n/aup+5.0%62n/a6.48No estimate
SHILPAMED Shilpa Medicare LtdHealthcare313n/aup+20.4%2n/a0.09No estimate
ASTRAZEN Astrazeneca Pharma India LtdHealthcare311n/aup+5.4%52n/a20.95No estimate
PGHL Procter & Gamble Health LtdHealthcare305n/aup+1.3%66n/a39.50No estimate
INDSWFTLAB Ind-Swift Laboratories LtdHealthcare290n/adown−6.5%32n/a5.36No estimate
INNOVACAP Innova Captab LtdHealthcare283n/aup+21.5%23n/a4.77No estimate
CONCORDBIO Concord Biotech LtdHealthcare262n/aup+34.4%84n/a8.08No estimate
COHANCE Cohance Lifesciences LtdHealthcare231n/adown−33.6%80n/a3.13No estimate
GUFICBIO Gufic BioSciences LtdHealthcare215n/aup+10.3%23n/a2.39No estimate
BLISSGVS Bliss GVS Pharma LtdHealthcare212n/aup+32.5%43n/a4.05No estimate
SANOFICONR Sanofi Consumer Healthcare India LtdHealthcare210n/an/a71n/a—No estimate
ORCHPHARMA Orchid Pharma LtdHealthcare199n/aup+8.7%20n/a3.90No estimate
BI Bilcare LtdHealthcare190n/aup+4.4%−12n/a−3.22No estimate
BLUEJET Blue Jet Healthcare LtdHealthcare181n/aup+0.6%48n/a2.76No estimate
ACUTAAS Acutaas Chemicals LtdHealthcare172n/aup+11.7%−17n/a−2.55No estimate
VENUSREM Venus Remedies LtdHealthcare168n/aup+76.8%10n/a7.44No estimate
SMSPHARMA SMS Pharmaceuticals LtdHealthcare167n/aup+23.7%12n/a1.38No estimate
ADVENZYMES Advanced Enzyme Technologies LtdHealthcare158n/aup+7.5%35n/a3.08No estimate
LINCOLN Lincoln Pharmaceuticals LtdHealthcare156n/aup+14.7%28n/a13.80No estimate
RPGLIFE RPG Life Sciences LtdHealthcare154n/aup+4.1%26n/a15.64No estimate
WINDLAS Windlas Biotech LtdHealthcare153n/aup+5.5%14n/a6.75No estimate
KOPRAN Kopran LtdHealthcare153n/aup+30.4%14n/a2.86No estimate
ANUHPHR Anuh Pharma LtdHealthcare150n/adown−6.8%14n/a1.38No estimate
WANBURY Wanbury LtdHealthcare144n/adown−1.3%7n/a2.25No estimate
PANACEABIO Panacea Biotec LtdHealthcare143n/aup+10.7%−8n/a−1.35No estimate
Emergy Phaarma Ltd Healthcare143n/aup+55.8%−4n/a−3.65No estimate
SUPRIYA Supriya Lifescience LtdHealthcare140n/aup+6.1%24n/a2.97No estimate
CHANDRABHAGATPHARMALTD Healthcare119up+170.5%n/a1n/a0.83No estimate
INDSWFTLTD Ind-Swift Ltd(Merged)Healthcare116up+11.5%down−22.1%−11n/a−1.98No estimate
THEMISMED Themis Medicare LtdHealthcare105n/aup+8.2%11n/a1.23No estimate
Tonira Pharma Ltd(merged) Healthcare103n/adown−15.6%16n/a2.29No estimate
BAJAJHCARE Bajaj Healthcare LtdHealthcare101n/adown−22.3%−3n/a−1.25No estimate
MHHL Mohini Health & Hygiene LtdHealthcare101up+2.0%n/a50.0%2.83No estimate
AMRUTANJAN Amrutanjan Health Care LtdHealthcare99n/aup+27.5%7n/a2.37No estimate
SIGACHI Sigachi Industries LtdHealthcare99n/aup+17.1%15n/a0.49No estimate
ALBERTDAVD Albert David LtdHealthcare93n/aup+1.1%20n/a35.57No estimate
BALPHARMA Bal Pharma LtdHealthcare93n/aup+31.5%1n/a0.61No estimate
ZIMLAB Zim Laboratories LtdHealthcare86n/aup+27.3%4n/a0.85No estimate
FREDUN Fredun Pharmaceuticals LtdHealthcare82n/aup+32.3%4n/a2.79No estimate
MANGALAM Mangalam Drugs and Organics LtdHealthcare82n/adown−6.7%−4n/a−2.25No estimate
SAMRATPHARMACHEMLTD Healthcare80n/aup+38.7%0n/a−0.61No estimate
NGLFINE NGL Fine Chem LtdHealthcare79n/aup+14.5%11n/a17.76No estimate
NOVARTIND Novartis India LtdHealthcare79n/adown−13.2%24n/a9.59No estimate
KPL Kwality Pharmaceuticals LtdHealthcare70n/aup+4.5%6n/a6.01No estimate
HESTERBIO Hester Biosciences LtdHealthcare70n/adown−20.5%4n/a4.81No estimate
HALEOSLABS Haleos Labs LimitedHealthcare69n/adown−7.2%0n/a2.25No estimate
COREPARENT Core Healthcare LtdHealthcare69n/an/a6n/a4.75No estimate
ZENITHDRUG Zenith Drugs LtdHealthcare69n/an/a6n/a4.75No estimate
MONOPHARMA Mono Pharmacare LtdHealthcare67n/an/a2n/a1.06No estimate
VIMTALABS Vimta Labs LtdHealthcare64n/adown−22.0%6n/a1.34No estimate
SYNCOMF Syncom Formulations (India) LtdHealthcare62n/aup+5.1%6n/a0.07No estimate

About Q2 FY24 earnings data

When are Q2 FY24 results announced?
Q2 FY24 covers the Jul–Sep 2023 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.
Why do some Q2 FY24 growth figures show "n/a" instead of a percentage?
Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.
Does the beat/miss verdict cover every company?
No analyst consensus was available for Q2 FY24, so no beat/miss verdict is shown. Revenue and profit growth are taken from reported results and cover every company in the table.
What counts as an in-line result rather than a beat or a miss?
Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.
Are the figures consolidated or standalone?
Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.
What does the 8-quarter trend line show?
Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.
How do I find only the companies that beat estimates in Q2 FY24?
Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.